1. Carberry, P., Lieberman, B.P., Ploessl, K., Choi, S.R., Haase, D.N., Kung, H.F. New F-18 prosthetic group via oxime coupling. Bioconjug Chem, 2011;22(4):642–53 https://pubmed.ncbi.nlm.nih.gov/21452846/
2. Valdivia A.O., López J.L. ,Vargas-Rodríguez Y.M. y González O.C., Producción de radiofármacos para tomografía por emisión de positrones (PET) y su aplicación en el diagnóstico de diversas enfermedades, México, Universidad Nacional Autónoma de México, 2016, https://www.elsevier.es/es-revista-educacion-quimica-78-articulo-produccion-radiofarmacos-tomografia-por-emision-S0187893X16300076
3. Ermet J., Naumaier B., The radiopharmaceutical chemistry of fluorine-18: nucleophilic fluorination, Radiopharmaceutical chemistry, Switzerland, Springer Nature Switzerland AG, 2019
4. Kilbourn M.R., Fluorine-18 labeling of radiopharmaceuticals, Washington, DC: The National Academies Press, 1990 https://www.nap.edu/catalog/20467/fluorine-18-labeling-of-radiopharmaceuticals
5. Z. Li, P.S. Conti, Radiopharmaceutical chemistry for positron emission tomography. Adv. Drug Deliv. Rev. 62, 1031–1051 (2010). https://doi.org/10.1016/j.addr.2010.09.007